A Plus Biotechnology Co., Ltd. (TPE:6918)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Adjustment and Write-Off	-66.58M	-60.45M	-72.38M
China	175.30M	161.55M	151.52M
Taiwan	727.17M	668.50M	595.90M
Total	835.89M	769.59M	675.05M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Taiwan	653.27M	590.88M	515.49M
China	175.30M	161.55M	151.52M
Others	7.32M	17.17M	8.04M
Total	835.89M	769.59M	675.05M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error